Selective Cytotoxic Activity of a Novel Ribonucleoside Diphosphate Reductase Inhibitor MDL-101, 731 against Thyroid Cancer in vitro

Folia Biologica

Volumn 45, Issue 5, 1999, Pages 185-192

  Kotchetkov, R ^a,b,c   Krivtchik, A A ^a   Cinatl, J ^a   Kornhuber, B ^a   Cinatl Jr , J ^a  

^a Practice for Hematology and Oncology   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c Medical Academy   (Belarus)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DNA FRAGMENT; ENZYME INHIBITOR; RIBONUCLEOSIDE DIPHOSPHATE REDUCTASE; TEZACITABINE;

APOPTOSIS; ARTICLE; ASSAY; CELL GROWTH; CELL LINE; CHERNOBYL ACCIDENT; CONTROLLED STUDY; CYTOTOXICITY; DNA SYNTHESIS; FIBROBLAST; FLOW CYTOMETRY; GENE EXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; THYROID CANCER;

EID: 0032854017     PISSN: 00155500     EISSN: 25337602     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Basolo, F., Pollina, L., Fontanini, G., Fiore, L., Pacini, F., Baldanzi, A. (1997) Apoptosis and proliferation in thyroid carcinoma: correlation with bcI-2 and p53 protein expression. Br. J. Cancer 75, 537-541.
2. Bitonti, A. J., Dumont, J. A., Bush, T. L., Cashman, E. A., Cross-Doersen, D. E., Wright, P. S., Matthews, D. P., McCarthy, J. R., Kaplan, D. A. (1994) Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene) cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res. 54, 1485-1490.
3. Bitonti, A. J., Bush, T. L., Lewis, M. T., Sunkara, P. S. (1995) Response of human colon and prostate tumor xenografts to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleotide reductase. Anticancer Res. 15, 1179-1182.
4. Bridges, C. G., Ahmed, S. P., Sunkara, P. S., McCarthy, J. R., Tyms, A. S. (1995) The ribonucleotide reductase inhibitor (E)-2'-fluoromethylene-2'-deoxycytidine (MDL-101, 731): a potential topical therapy for herpes simplex virus infection. Antiviral Res. 27, 325-334.
5. Cherstvoy, E., Pozcharskaya, V., Harach, H. R., Thomas, G. A., Williams, E. D. (1996) The pathology of childhood thyroid carcinoma in Belarus. In: The Radiological Consequences of the Chernobyl Accident, ERU 16544 EN, eds. Karaoglou, A., Desmet, G., Kelly, G. N., Menzel, H. G., pp. 785-789, European Commision, Luxemburg.
6. Chiu, S. K., Rao, L., White, E. (1994) Bcl-2 blocks p53 dependent apoptosis. Mol. Cell. Biol. 14, 2556-2563.
7. Cinatl, J. Jr., Cinatl, J., Weber, B., Rabenau, H., Gümbel. H. O., Chenot, J.-F., Scholz, M., Encke, A., Doerr, H. W. ( 1995) In vitro inhibition of human cytomegalovirus replication in human foreskin fibroblasts and endothelial cells by ascorbic acid 2-phosphate. Antiviral Res. 27, 405-418.
8. Cinatl, J. Jr., Cinatl, J., Vogel, J.-U., Kotchetkov, R., Hernäiz Driever, P., Kabickova, H., Kornhuber, B., Schwabe, D., Doerr, H. W. (1998) Persistent human cytomegalovirus infection induces drug resistance and alterations of programmed cell death in human neuroblastoma cells. Cancer Res. 15, 367-372.
9. Craig, R. W. (1995) The Bcl-2 gene family. Semin. Cancer Biol. 6, 35-43.
10. Droz, J.-P., Schlumberger, M., Rougier, Ph., Ghosn, M., Gardet, P., Parmentier, C. (1990) Chemotherapy in metastatic nonanaplastic thyroid cancer: experience at the Institute Gustave-Roussy. Tumori 76, 480-483.
11. Fox, R. M. (1993) Changes in deoxynucleoside triphosphate pools, induced by inhibitors and modulators of ribonucleotine reductase. Phannacol. Ther. 30, 31-42.
12. Gerein, V., Kruglova, N., Furmanchuk, D., Dokutchaev, A. ( 1993) The first positive results of chemotherapy of children with lung métastases of differentiated thyroid cancer. Actual questions of children oncology. Abstract Book of the First Belomssian Congress of Children Oncology. Minsk, Belarus, A18.
13. Gottlieb, J. A., HilI, C.S.Jr.(1975)Adriamycin(NSC-123127) therapy in thyroid carcinoma. Cancer Chemother. Rep. 6, 283-296.
14. Kanada, M., Aime-Sempe, C., Sato, T., Reed, J. C. (1995) Structure-function analysis of Bcl-2 protein. Identification of conserved domains important for homodimerization with Bax.J. Biol. Cliem. 270, 11962-11969.
15. Hannun, Y. A. (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89, 1845-1853.
16. Hoskin, P. J., Harmer, C. (1987) Chemotherapy for thyroid cancer. Radiother. Oncol. 10, 87-194.
17. Huang, P., Plunkett, W. (1995) Induction of apoptosis by gemcitabine. Semin. Oncol. 22, 19-25.
18. Jansen, B., Schlagbauer-Wadl, H., Brown, B. D., Bryan, R. N., Van Elsas, A., Müller, M., Wolf, K., Eichler, H. G. G., Pehamberger, H. (1998) Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nature Medicine 4, 232-234.
19. Johnson, C. A., Forster, T. H., Winterford, C. M., Allan, D. J. (1992) Hydroxyurea induces apoptosis and regular DNAfragmentation in Burkitt's lymphoma cell line. Biochim. Biophys. Acta 1136, 1-4.
20. Kandouz, M., Compel, A., Therwath, A. (1996) Bcl-protooncogene, apoptosis and oncogenesis: an overview. Int. J. Oncol 9, 563-566.
21. Kazakov, U. S., Demidchik, E. P., Astakhova, L. N. (1992) Thyroid cancer after Chernobyl. Nature 359, 21-22.
22. Kenady, D. E., Sloan, D. A., Schwanz, R. W. (1992) Diagnosis and treatment of thyroid, adrenal, and thymic tumors. Curr. Opin. Oncol. 4, 89-98.
23. Kotchetkov, R., Gröschel, B., Cinatl, J., Rabenau, H., Doerr, H. W., Kornhuber, B., Cinatl, J. Jr. (1997) Zidovudine induces resistance to antineoplastic agents and alterations in apoptosis in T-cell lymphoma cells. In: Acute Leukemias VII: Experimental Approaches and Novel Therapies. Eds. Hiddemann, W., Büchner, T., pp. 469-474, Springer-Verlag, Berlin-Heidelberg.
24. Landowski, T. H., Gleason-Guzman, M. C., Dalton, W. S. (1997) Selection for drug resistance results in resistance to Fas-mediated apoptosis. Blood 89, 1854-1861.
25. Leist, M., Gantner, F., Bohlinger, L, Germann, P. G., Tiegs, G., Wendel, A. (1994) Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-cc requires transcriptional arrest. J. Immunol. 153, 1778-1788.
26. McCarthy, J. R., Mattews, D. P., Stermerick, D., Huber, E., Bey, P., Lippert, B., Snyder, R., Sunkara, P. (1990) Stereospecific method to E and Z terminal fluoroolefins and its application to the synthesis of 2'-deoxy-2'-fluoromethylene nucleosides as potential inhibitors of ribonucleoside diphosphate reductase. J. Am. Chem. Soc. 113, 7439-7440.
27. Min, Y. N., Lee, S., Lee, J. W., Chong, S. Y., Hahn, J. S., Ko, Y. W. (1996) Expression of Fas antigen in acute myeloid leukemia is associated with therapeutic response to chemotherapy. Br. J. Haematol. 4, 928-930.
28. Mosmann, T. (1983) Rapid colorometric assay for cellular growth and survival. Application to proliferation and cytotoxicity assays. J. Immunol. Meth. 65, 55-64.
29. Nagata, S., Golstein, P. (1995) The Fas death factor. Science 267, 1449-1456.
30. Pacini, F., Vorontsova, T., Demidchik, E. P., Molinaro, E., Agate, L., Romei, C., Shavrova, E., Cherstvoy, E. D., Ivashkevitch, Y., Kuchinskaya, E., Schlumberger, M., Ronga, G., Filesi, M., Pinchera, A. (1997) Post-Chemobyl thyroid carcinoma in Belarus children and adolescents: comparison with naturally occurring thyroid carcinoma in Italy and France. J. Clin. Endocrmol. Metab. 82, 3563-3569.
31. Pernal, J., Pawlicki, M., Zuchowska-Vogelgesang, B., JazwaOrtyl, E. (1992) Role of chemotherapy in treatment of anaplastic thyroid cancer - our experience. (In Polish). Endokrynologia Polska 43, 437-442.
32. Piepmeier, L. M., Rabidou, N., Schold, S. C. Jr., Bitonti, A. J., Prakash, J., Bush, T. (1996) In vitro and in vivo inhibition of glioblastoma and neuroblastoma with MDL-101, 731, a novel ribonucleoside diphosphate reductase inhibitor. Cancer Res. 56, 359-361.
33. Plunkett, W., Gandhi, V., Chubb, S., Nowak, B., Heinemann, V., Mineishi, S., Sen, A., Hertel, L. W., Grindley, G. B. (1989) 2', 2'-difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides Nucleotides 8, 775-785.
34. Rokhlin, 0. W., Bishop, G. A., Hostager, B. S., Waldschmidt, T. J., Sidorenko, S. P., Pavloff, N., Kiefer, M. C., Umansky, S. R., Glover, R. A., Cohen, M. B. (1997) Fas-mediated apoptosis in human prostatic carcinoma cell lines. Cancer Res. 57, 1758-1768.
35. Tanimoto, C., Hirakawa, S., Kawasaki, H., Hayakawa, N., Ota, Z. (1995) Apoptosis in thyroid diseases: a histochemical study. Endocrinol. J. 42, 193-201.
36. Williams, G. T. (1991) Programmed cell death: apoptosis and oncogenesis. Cell 65, 1097-1098.
37. Williams, B. A., Makrigiannis, A. P., Blay, J., Hoskin, D. W. (1997) Treatment of the P815 murine mastocytoma with cisplatin or etoposide up-regulates cell-surface Fas (CD95) expression and increases sensitivity to anti-Fas antibodymediated cytotoxicity and to lysis by anti-CDS-activated killer-T-cells. Int. J. Cancer 73, 416-423.
38. Yang, E., Korsmeyer, S. J. (1996) Molecular thanatopsis: a discourse on the bcl-2 family and cell death. BloodSS, 386-401.